NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 64 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $826,000 | -16.9% | 371,944 | -7.2% | 0.00% | – |
| Q4 2020 | $994,000 | +1.2% | 400,857 | +0.4% | 0.00% | – |
| Q3 2020 | $982,000 | -32.2% | 399,152 | -2.2% | 0.00% | – |
| Q2 2020 | $1,449,000 | +280.3% | 407,932 | +55.5% | 0.00% | – |
| Q2 2019 | $381,000 | -31.6% | 262,351 | -7.2% | 0.00% | – |
| Q1 2019 | $557,000 | +53.4% | 282,782 | +1.9% | 0.00% | – |
| Q4 2018 | $363,000 | -45.7% | 277,557 | +2.2% | 0.00% | – |
| Q3 2018 | $668,000 | -27.1% | 271,531 | -0.5% | 0.00% | – |
| Q2 2018 | $916,000 | -13.7% | 272,825 | +8.7% | 0.00% | – |
| Q1 2018 | $1,062,000 | +30.8% | 250,997 | +2.1% | 0.00% | – |
| Q4 2017 | $812,000 | -15.6% | 245,820 | -2.3% | 0.00% | – |
| Q3 2017 | $962,000 | +383.4% | 251,610 | +455.4% | 0.00% | – |
| Q2 2017 | $199,000 | – | 45,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
| WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
| Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
| FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
| FT Options LLC | 10,000 | $26,000 | 0.02% |
| WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
| NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
| Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |